Season 1, Episode 12: The Future of Immuno-Oncology with Mark Frohlich
Michael Pietrack sits down with Mark Frohlich, a Harvard-trained medical Oncologist and CEO of Indapta Therapeutics! He discusses his experience in the Pharmaceutical industry as a pioneer in Immuno-Oncology. He emphasizes the importance of understanding the immune system and the integration of different approaches, including the role of artificial intelligence.
Regarding leadership, Frohlich highlights the importance of focusing on tasks that only the leader can do, giving honest feedback, and seeking out mentors for career development.
Key Points:
👨⚕️ Understanding the immune system is crucial in developing effective immunotherapies.
🔜The future of immunotherapy lies in integrating different approaches and leveraging artificial intelligence.
✋As a CEO, focus on tasks that only you can do and delegate other responsibilities.
🔰The "Kind Truth" help employees perform at their best.
📚Seek out mentors for guidance and career development.